Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Characterization of a diffuse intrinsic pontine glioma cell line: implications for future investigations and treatment.

Hashizume R, Smirnov I, Liu S, Phillips JJ, Hyer J, McKnight TR, Wendland M, Prados M, Banerjee A, Nicolaides T, Mueller S, James CD, Gupta N.

J Neurooncol. 2012 Dec;110(3):305-13. doi: 10.1007/s11060-012-0973-6. Epub 2012 Sep 17.

PMID:
22983601
2.

Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas.

Barrow J, Adamowicz-Brice M, Cartmill M, MacArthur D, Lowe J, Robson K, Brundler MA, Walker DA, Coyle B, Grundy R.

Neuro Oncol. 2011 Feb;13(2):212-22. doi: 10.1093/neuonc/noq158. Epub 2010 Dec 7.

3.

Patient-derived Tumor Models for Diffuse Intrinsic Pontine Gliomas.

Hashizume R, Gupta N.

Curr Neuropharmacol. 2017;15(1):98-103. Review.

4.

Morphologic characteristics and immunohistochemical profile of diffuse intrinsic pontine gliomas.

Ballester LY, Wang Z, Shandilya S, Miettinen M, Burger PC, Eberhart CG, Rodriguez FJ, Raabe E, Nazarian J, Warren K, Quezado MM.

Am J Surg Pathol. 2013 Sep;37(9):1357-64. doi: 10.1097/PAS.0b013e318294e817.

5.

Measuring the pons: a non-invasive biomarker for pediatric diffuse intrinsic pontine glioma.

Warren KE.

CNS Oncol. 2014 May;3(3):181-3. doi: 10.2217/cns.14.10. No abstract available.

PMID:
25055124
6.

Clinicopathology of diffuse intrinsic pontine glioma and its redefined genomic and epigenomic landscape.

Panditharatna E, Yaeger K, Kilburn LB, Packer RJ, Nazarian J.

Cancer Genet. 2015 Jul-Aug;208(7-8):367-73. doi: 10.1016/j.cancergen.2015.04.008. Epub 2015 May 1. Review.

PMID:
26206682
7.

Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma.

Choi SA, Hwang SK, Wang KC, Cho BK, Phi JH, Lee JY, Jung HW, Lee DH, Kim SK.

Neuro Oncol. 2011 Jan;13(1):61-9. doi: 10.1093/neuonc/noq147. Epub 2010 Nov 9.

8.

Diffuse intrinsic pontine gliomas: treatments and controversies.

Bredlau AL, Korones DN.

Adv Cancer Res. 2014;121:235-59. doi: 10.1016/B978-0-12-800249-0.00006-8. Review.

PMID:
24889533
9.

Glioblastoma spheroids produce infiltrative gliomas in the rat brainstem.

Zhou Z, Luther N, Singh R, Boockvar JA, Souweidane MM, Greenfield JP.

Childs Nerv Syst. 2017 Mar;33(3):437-446. doi: 10.1007/s00381-017-3344-y. Epub 2017 Feb 24.

PMID:
28236065
10.

Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets.

Zarghooni M, Bartels U, Lee E, Buczkowicz P, Morrison A, Huang A, Bouffet E, Hawkins C.

J Clin Oncol. 2010 Mar 10;28(8):1337-44. doi: 10.1200/JCO.2009.25.5463. Epub 2010 Feb 8.

PMID:
20142589
11.

Diffuse intrinsic pontine glioma: time for therapeutic optimism.

Khatua S, Zaky W.

CNS Oncol. 2014;3(5):337-48. doi: 10.2217/cns.14.37. Review.

PMID:
25363006
12.

Comparative expression analysis reveals lineage relationships between human and murine gliomas and a dominance of glial signatures during tumor propagation in vitro.

Henriquez NV, Forshew T, Tatevossian R, Ellis M, Richard-Loendt A, Rogers H, Jacques TS, Reitboeck PG, Pearce K, Sheer D, Grundy RG, Brandner S.

Cancer Res. 2013 Sep 15;73(18):5834-44. doi: 10.1158/0008-5472.CAN-13-1299. Epub 2013 Jul 25.

13.

Malignant brainstem tumors in children, excluding diffuse intrinsic pontine gliomas.

Klimo P Jr, Nesvick CL, Broniscer A, Orr BA, Choudhri AF.

J Neurosurg Pediatr. 2016 Jan;17(1):57-65. doi: 10.3171/2015.6.PEDS15166. Epub 2015 Oct 16.

PMID:
26474099
14.

Management of diffuse intrinsic pontine glioma in children: current and future strategies for improving prognosis.

Kaye EC, Baker JN, Broniscer A.

CNS Oncol. 2014 Nov;3(6):421-31. doi: 10.2217/cns.14.47. Review.

PMID:
25438813
15.

Monitoring of tumor growth and post-irradiation recurrence in a diffuse intrinsic pontine glioma mouse model.

Caretti V, Zondervan I, Meijer DH, Idema S, Vos W, Hamans B, Bugiani M, Hulleman E, Wesseling P, Vandertop WP, Noske DP, Kaspers G, Molthoff CF, Wurdinger T.

Brain Pathol. 2011 Jul;21(4):441-51. doi: 10.1111/j.1750-3639.2010.00468.x. Epub 2010 Dec 29.

PMID:
21159008
16.

Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications.

Buczkowicz P, Bartels U, Bouffet E, Becher O, Hawkins C.

Acta Neuropathol. 2014 Oct;128(4):573-81. doi: 10.1007/s00401-014-1319-6. Epub 2014 Jul 22.

17.

A new era for children with diffuse intrinsic pontine glioma: hope for cure?

Jansen MH, Kaspers GJ.

Expert Rev Anticancer Ther. 2012 Sep;12(9):1109-12. doi: 10.1586/era.12.95. No abstract available.

PMID:
23098109
18.

Diffuse intrinsic brainstem tumors in neonates. Report of two cases.

Shah NC, Ray A, Bartels U, Rutka J, Bouffet E, Drake J, Hawkins CE, Huang A.

J Neurosurg Pediatr. 2008 May;1(5):382-5. doi: 10.3171/PED/2008/1/5/382.

PMID:
18447673
19.

The efficacy of a biopsy of intrinsic brainstem lesions for decision making of the treatments.

Ogiwara H, Morota N.

Childs Nerv Syst. 2013 May;29(5):833-7. doi: 10.1007/s00381-013-2042-7. Epub 2013 Feb 3.

PMID:
23377758
20.

Management and outcome of focal low-grade brainstem tumors in pediatric patients: the St. Jude experience.

Klimo P Jr, Pai Panandiker AS, Thompson CJ, Boop FA, Qaddoumi I, Gajjar A, Armstrong GT, Ellison DW, Kun LE, Ogg RJ, Sanford RA.

J Neurosurg Pediatr. 2013 Mar;11(3):274-81. doi: 10.3171/2012.11.PEDS12317. Epub 2013 Jan 4.

Supplemental Content

Support Center